LXR agonist 4
LXR agonist 4 is a selective LXR inverse agonist with IC50 values of 7.6 (LXRα) and 2.9 μM (LXRβ), respectively. LXR agonist 4 exhibits selectivity over RORα and FXR. LXR agonist 4 robustly suppresses SREBP1c expression without altering ABCA1 or APOE. LXR agonist 4 displays antilipogenic properties and resolves fatty acid-induced steatosis. LXR agonist 4 can be used for the research of atherosclerosis and metabolic dysfunction-associated steatotic liver disease (MASLD).
For research use only. We do not sell to patients.
- Formula: C36H31ClF3NO2S
- Molecular Weight:634.15
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
LXRα 7.6 μM (IC50) |
LXRβ 2.9 μM (IC50) |
LXR agonist 4 (compound 3) (30 μM; 4-24 h) does not inhibit the proliferation of HEK293T or HepG2 cells[1].
LXR agonist 4 (30 μM; 24 h) suppresses SREBP1c expression without altering ABCA1 or APOE in HepG2 cells[1].
LXR agonist 4 (30 μM; 72 h) displays antilipogenic properties and resolves fatty acid-induced steatosis in HepG2 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HEK293T and HepG2
-
Concentration:30 μM
-
Incubation Time:4, 14, and 24 h
-
Result:Showed no significant inhibition of proliferation in HEK293T and HepG2 cells over 24 hours.
Chemical Information
-
Molecular Weight 634.15
-
Formula C36H31ClF3NO2S
-
SMILES
CS(C1=CC=CC(C2=CC=C(C=C2)CN(CC(C3=CC=CC=C3)C4=CC=CC=C4)CC5=CC=CC(C(F)(F)F)=C5Cl)=C1)(=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)